Were Ilan Daskal’s VIAV share sales executed at multiple prices?

Yes. The filing states the transactions were executed in multiple trades at prices ranging from $36.25 to $36.42 per share, with the reported $36.29 reflecting the weighted average sale price.

Viavi CFO sells 56K shares around $36 each

Q: What insider transaction did VIAV report for EVP, CFO Ilan Daskal?

VIAVI Solutions (VIAV) reported that EVP, CFO Ilan Daskal sold a total of 56,290 shares of common stock on 2026-08-31 in two open-market or private sale transactions.

Q: How many VIAV shares did Ilan Daskal sell in each transaction?

On 2026-08-31, Ilan Daskal sold 30,257 shares of VIAVI common stock in one transaction and 26,033 shares in a second transaction, for a combined total of 56,290 shares sold.

Q: What was the sale price of the VIAV shares sold by Ilan Daskal?

The reported price for each sale by Ilan Daskal was a weighted average of $36.29 per share. According to the footnote, individual trades were executed at prices ranging from $36.25 to $36.42 per share.

Q: Does the Form 4 disclose Ilan Daskal’s remaining VIAV holdings after the sale?

No. The Form 4 reports the 56,290 shares of VIAVI common stock sold but does not state the total number of shares beneficially owned following the reported transactions.

VIAVI SOLUTIONS INC.

Filing Impact

(Neutral)

Filing Sentiment

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

VIAVI SOLUTIONS INC. (VIAV) reported that EVP and CFO Ilan Daskal sold a total of 56,290 shares of common stock on 2026-08-31 in two open-market or private transactions. The sales, totaling 30,257 and 26,033 shares, were executed at a weighted average price of $36.29 per share, with individual trade prices ranging from $36.25 to $36.42. Post-transaction share holdings were not reported in this filing.

Insider Trade Summary

Net Seller: 56,290 shares

Net Sell 2 txns

Insider Daskal Ilan

Role EVP, CFO

Sold 56,290 shs ($2.04M)

Type	Security	Shares	Price	Value
Sale	Common Stock ^F1	30,257	$36.29	$1.10M
Sale	Common Stock ^F1	26,033	$36.29	$945K

Holdings After Transaction: Common Stock — 10,132 shares (Direct)

Footnotes (1)

F1. This transaction was executed in multiple trades at prices ranging from $36.25 to $36.42. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Key Figures

Shares sold (first transaction): 30,257 shares of Common Stock Shares sold (second transaction): 26,033 shares of Common Stock Total shares sold: 56,290 shares of Common Stock +3 more

6 metrics

Shares sold (first transaction) 30,257 shares of Common Stock Sale reported on 2026-08-31 by EVP, CFO Ilan Daskal

Shares sold (second transaction) 26,033 shares of Common Stock Sale reported on 2026-08-31 by EVP, CFO Ilan Daskal

Total shares sold 56,290 shares of Common Stock Aggregate of two sale transactions on 2026-08-31

Weighted average sale price $36.29 per share Price reported for each of the 2026-08-31 sale transactions

Trade price range $36.25 to $36.42 per share Range of prices at which individual trades were executed on 2026-08-31

Number of sale transactions 2 transactions Non-derivative sales of common stock reported for 2026-08-31

Key Terms

weighted average sale price, open market or private transaction, beneficially owned following

3 terms

weighted average sale price financial

"The price reported above reflects the weighted average sale price."

open market or private transaction financial

"Sale in open market or private transaction"

beneficially owned following financial

"total_shares_following_transaction"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did VIAV report for EVP, CFO Ilan Daskal?

VIAVI Solutions (VIAV) reported that EVP, CFO Ilan Daskal sold a total of 56,290 shares of common stock on 2026-08-31 in two open-market or private sale transactions.

How many VIAV shares did Ilan Daskal sell in each transaction?

On 2026-08-31, Ilan Daskal sold 30,257 shares of VIAVI common stock in one transaction and 26,033 shares in a second transaction, for a combined total of 56,290 shares sold.

What was the sale price of the VIAV shares sold by Ilan Daskal?

The reported price for each sale by Ilan Daskal was a weighted average of $36.29 per share. According to the footnote, individual trades were executed at prices ranging from $36.25 to $36.42 per share.

Does the Form 4 disclose Ilan Daskal’s remaining VIAV holdings after the sale?

No. The Form 4 reports the 56,290 shares of VIAVI common stock sold but does not state the total number of shares beneficially owned following the reported transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 08/31/2026 - 02:16 PM EDT Accepted by SEC EDGAR 08/31/2026 - 02:16 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Daskal Ilan

(Last)

(First)

(Middle)

C/O VIAVI SOLUTIONS INC.

1445 SOUTH SPECTRUM BLVD, SUITE 102

(Street)

CHANDLER

ARIZONA

85286

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
VIAVI SOLUTIONS INC. [ VIAV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP, CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	08/31/2026		S		30,257	D	$36.29⁽¹⁾	36,165	D
Common Stock	08/31/2026		S		26,033	D	$36.29⁽¹⁾	10,132	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. This transaction was executed in multiple trades at prices ranging from $36.25 to $36.42. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

	/s/ Donna T. Rossi, attorney-in-fact	08/31/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR